Harpoon Therapeutics, Inc. announced the appointment of Lauren Silvernail to its Board of Directors and as the Chairperson of its Audit Committee. Lauren Silvernail has three decades of experience in lead financial and business development roles. She has led and played key roles in a broad range of transactions, including mergers, acquisitions, and financings.

She most recently served as Chief Financial Officer and Executive Vice President of Corporate Development of Evolus, Inc., an aesthetic medicine company, where she led fundraising activities and helped establish the infrastructure for the U.S. commercial launch of the company's first approved product. Previously, she served as Chief Financial Officer and Chief Business Officer at Revance Therapeutics, Inc. and held corporate development roles at ISTA Pharmaceuticals Inc., Allergan and other companies. Lauren is currently a member of the Board of Directors of Nicox S.A., an international ophthalmology company.

She earned an M.B.A. in finance and accounting from the Anderson Graduate School of Management at UCLA, and a B.A. in biophysics from the University of California, Berkeley.